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geriatric dentistry
Head and neck malignancies can be difficult to treat, es-
pecially in the geriatric population. A dental approach 
toward interprofessional management, treatment plan-
ning and rehabilitation of diagnosed individuals under-
going cancer therapies is essential. This literature review 
focuses primarily on: presurgery oral hygiene instruc-
tions; pre-radiotherapy/chemotherapy dental clearance; 
complications and management during radiotherapy/
chemotherapy; post-radiotherapy/chemotherapy oral 
healthcare; and adjunctive measures. Each section aims 
to affirm that thorough evaluation is vital to understand-
ing the assessment and safe management of patients un-
dergoing oncology treatment. Furthermore, this project 
will help establish guidelines for interprofessional nurs-
ing home teams in regards to oral healthcare. 
Head and neck cancer (HNC) constitutes less than 5% of all 
cancers, but it can have devastating outcomes in the lives of af-
fected patients.1-2 In 2001, there were approximately 30,000 HNC- 
related deaths in the United States.1 It has been linked to several 
causes, including tobacco use and/or alcohol consumption. 
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A B S T R A C T
Eighty percent to ninety percent of head and neck cancers are due 
to tobacco and alcohol use. Traditionally, men over the age of 40 
who smoke have the highest risk of developing HNC, squamous 
cell carcinoma (SCC). A recent study showed that development 
of oral cancer in smokers increases with age. Men who stopped 
smoking at 30 years of age had a 1.2% risk of developing SCC, 
while men 75 years of age and older who continued smoking had 
a 6.3% risk of developing cancer of the upper digestive tract.1 
The incidence of human papilloma virus (HPV)-related 
squamous cell carcinoma has increased in the last 20 to 30 years. 
This disease usually occurs in the region of the oropharynx in 
patients who are 45 years or younger, so it is not usually a risk 
factor in the geriatric population. HPV-related SCC is discovered 
at a later stage, but it responds better to radiation treatment com-
pared to non-HPV-related squamous cell carcinoma. Deficiencies 
of vitamin A and iron, occupational exposure to toxic chemicals 
and genetic abnormalities have also been linked to the develop-
ment of cancer in the head and neck.2 Immunosenescence, which 
is defined as the changes that occur in the immune system due to 
increased age, may cause an increase in the risk of cancer.3
It has been postulated that by the year 2030, 20% of the 
overall population will be composed of individuals 65 years and 
older.4 The elderly, in particular, are at risk of developing cancer 
throughout the body, including the head and neck region. Ac-
cording to the American Cancer Society, people ages 55 and above 
represent 78% of all cancer diagnoses.5 Treatment modalities for 
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cancer, such as surgery, radiation and/or chemotherapy, can take 
a physical, psychological and financial toll on the affected indi-
viduals.6 Support from family, friends and nursing home staff can 
help these patients learn how to cope with their illness. 
Nursing homes are facilities that provide long-term residen-
tial accommodations and/or healthcare for patients who do not 
require hospitalization but do require 24-hour assistance.6-11 Ac-
cording to the Centers for Disease Control and Prevention, in 
2013, the United States had 15,700 nursing homes, with 1.4 
million beds out of a possible 1.7 million being occupied. While 
nursing homes provide healthcare to ensure a better quality of 
life, oral care has been found to be a low priority.6 Nurses form 
an integral part of the interdisciplinary team caring for patients 
before, during and after treatment.6 Dental professionals can as-
sist nurses with patients living in these facilities. 
For this study, the journals reviewed were published in Eng-
lish between 1975 and 2015 and contained information about 
the various types of cancers that occur in the head and neck 
region, along with treatment modalities and complications. 
Literature regarding dental care in nursing homes was also in-
cluded. Abstracts and continuing education course materials 
were excluded. Relevant websites and textbooks with informa-
tion related to the incidence of cancer and the care of affected 
patients were also used. This review will discuss pre-surgery oral 
hygiene instructions, pre-radiology/chemotherapy dental clear-
ance, during-radiology/chemotherapy dental complications and 
management, post-radiology/chemotherapy oral healthcare and 
adjunctive healthcare. The aim of this review is to explore guide-
lines for nursing home healthcare teams in regards to oral health 
and interprofessional collaboration. 
Presurgery Oral Hygiene
The healthcare team at a nursing home comprises family, physi-
cians, nursing staff, social workers, rehabilitation staff, physical 
therapists, occupational therapists, speech therapists and other 
non-medical personnel.6,12
As the population ages, physician visits increase, while den-
tal visits decrease for reasons ranging from the individual’s lack 
of awareness, changes in oral hygiene habits and inability to af-
ford dental care.7 The nursing home staff may require more en-
couragement in recognizing the importance of oral care in older 
populations. According to a study by Coleman and Watson, five 
nursing homes in New York State did not meet oral hygiene stan-
dards for their residents, such as brushing their teeth for at least 
two minutes, flossing, performing an oral assessment, rinsing 
with mouthwash and wearing gloves during the performance of 
oral care.13 The elderly are particularly at risk for the development 
of oral diseases that are gateways to other systemic disease, such 
as cardiovascular disease, stroke and respiratory infection.14 Thus, 
it is extremely important for the team at the nursing home to ad-
minister a rigorous oral care protocol. One of the most effective 
ways to ensure change is to include interdisciplinary collabora-
tion between nurses and dental professionals. 
The risk of squamous cell carcinoma increases after age 
65, so it is important that all staff be aware of the clinical 
manifestations. These include red and white mucosal lesions 
that cannot be wiped away and which should undergo biopsy 
if present for more than two weeks.3 Non-healing ulcers pres-
ent for more than two weeks should also be biopsied.2 HNC 
may present as ominous-appearing nodular growths, palpable 
swellings, constant sore throat and otitis media that do not 
respond to antibiotics, as well as non-trauma-induced and un-
controlled bleeding of the mucosa.2
Once a patient has been diagnosed with cancer, it is impor-
tant to increase oral hygiene measures. Cancer therapy can cause 
the oral cavity to undergo many changes, so it is best to establish a 
good regimen. Patients should be encouraged to cease all high-risk 
behaviors, such as smoking and excessive alcohol consumption.
Dental Clearance prior to Radiation and Chemotherapy
A comprehensive oral evaluation, prior to HNC treatment, is nec-
essary to identify and eliminate active or potential oral sources 
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of infection. In cancer patients, the most frequently documented 
source of sepsis is the oral cavity.15-20 Therefore, it is essential to 
evaluate and address dental needs for geriatric patients receiv-
ing oncology treatment. An early assessment of oral status and a 
means for providing care are critical in reducing potential com-
plications associated with cancer therapy.17
Pre-treatment Comprehensive Oral Evaluation
Ideally, the oral evaluation should occur several weeks prior to 
commencement of cancer treatment, to allow for adequate heal-
ing time.18,21,22 Medical consultation and thorough review of the 
patient’s dental history are needed to develop an appropriate 
treatment plan. The medical consultation should encompass in-
formation concerning the disease/condition and associated treat-
ment protocol, immunosuppression status, medications, allergies 
and contact information for the patient’s oncologist.17,23 
Dental health history must contain information regarding the 
patient’s previous dental care, symptomatic teeth, trauma, habits, 
fluoride exposure, caries risk assessment and oral hygiene.16 The 
assessment includes extraoral and intraoral clinical examinations, 
identification of existing infections and other compromised hard 
or soft issues, and an evaluation of relevant radiographs.16,24 
Dental and Systemic Care prior to Oncology Therapy
Upon completion of the oral examination, it is critical that the 
dentist communicate the findings and associated treatment plan 
to the oncologist. If the radiation oncologist determines that a de-
lay in cancer treatment will affect the potential success of disease 
control and patient survivability, pre-cancer dental care may not 
be advisable.25,26 The main focus should be on existing infections, 
extractions, periodontal care and sources of tissue irritation 
(Table 1).16,24,27,28 The team should educate the patient on proper 
oral hygiene, maintenance, nutrition and diet.24 Oral and maxil-
lofacial surgeons (OMS) play an important role in diagnosing HNC 
and patient management. The OMS is involved with cancer screen-
ings and patient education, and surgical therapy.29,30 The team ap-
proach will aid in reducing or eliminating complications, such as 
radiation mucositis, xerostomia and osteoradionecrosis.31,32 
In addition to a complete oral examination, a comprehen-
sive geriatric assessment (CGA) should be completed.33 Geriatric 
patients often present with comorbidities, such as narrow arter-
ies and decreased organ function, which may cause complications 
during surgery, radiation and chemotherapy. Chemotherapy- 
related toxicity is more common in elderly patients. This is caused 
by decreased liver and renal function, which allows abnormally high 
levels of chemotherapeutics to build up in the bloodstream.29,30,33 
CGA is a multidiscplinary evaluation of the patient’s nutritional 
status, co-morbid medical conditions, cognition, psychological 
state and functional status. This assessment will help determine 
what type of treatment the patient will be able to withstand.33 Sys-
temic health benefits and oral care are critical to the quality of life 
for geriatric patients undergoing oncology treatment.34 
TABLE 1.  
Oral and Dental Care Prior to Cancer Therapy
Dental Care Considerations Guidelines and Action
Surgical Considerations Vital and viable teeth should be retained for function, aesthetics, and quality of life.70 Nonetheless, it is significant to  
eliminate possible sources of infection.28
Due to the increased risk of osteoradionecrosis in irradiated bone with dental extractions or untreated infection, it is  
generally advised to extract teeth with poor long-term prognosis prior to radiotherapy.71 Ideally, extractions should be  
undertaken up to two weeks before commencement of radiotherapy.28,72 Teeth that should be considered for extraction  
include, but are not limited to:70 
● Extensive carious lesions with questionable pulpal status or involvement
● Extensive peri-apical lesions
● Moderate or advanced periodontal disease, with extensive attachment loss, bone loss and mobility or furcation involvement
● Residual root tip that is radiolucent or if not fully covered by alveolar bone
● Impacted or incompletely erupted teeth (third molars)71, 73, 74
Periodontal Considerations Scaling and prophylaxis with establishment and reinforcement of good oral hygiene and dietary advice. With emphasis  
on adequate hydration.75
Deep scaling and root planing (PD < 6 mm) should occur 14 days prior to radiotherapy for sufficient healing time.28
● Recommended mouthrinse with aqueous alcohol-free chlorhexidine gluconate mouthwash for short-term use.
Restorative Treatment Caries removal and restorations.
Smoothing of irregular teeth and sharp areas on restoration. Removal and replacement of defective restorations.74
Prosthetic Considerations Removable prostheses should be removed if any signs of ulceration.
Ill-fitting dentures should be relined, repaired, or replaced to avoid irritation and tissue trauma.23
Orthodontic Appliances Treatment should be discontinued.76
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Dental Complications and Management  
during Radiation/Chemotherapy Treatment
Oral or oropharyngeal mucositis (OM), an inflammatory disease 
of the oral and oropharyngeal mucosa, is commonly induced by 
ionizing radiation during radiation therapy (RT). Within three 
weeks, mucosal ulcerations manifest and become confluent.35 
These ulcerations may persist for up to six weeks after completion 
of RT and impair the patient’s ability to eat, speak and function 
properly. These lesions leave patients vulnerable to microbial in-
vasion of the bloodstream, increasing their risk of acquiring local 
or systemic infections.36,37
Therapeutic treatments, including soft laser and cryothera-
py, show increasing evidence of effectiveness in preventing and 
managing OM. Lack of significant evidence, however, has limited 
their approval or utilization. 
OM treatment is associated with symptom management.38 
As pain is typically present, treatment begins with topical analge-
sics or anesthetics, such as viscous lidocaine to help with OM.15 
Some clinicians will prescribe “magic mouthwash” to alleviate 
the pain associated with OM. There are many different formu-
las used to make magic mouthwash. Palifermin is the only FDA-
approved growth factor or cytokine-approved medication to treat 
oral mucositis.39-41 Alternating non-opioid oral analgesics, such 
as ibuprofen and Tylenol, is recommended if topical application is 
insufficient. If pain persists, opioids may be added, starting with 
the lowest effective dose and increasing as needed.38,42 
Low-level laser therapy (LLLT) is a new modality, which 
may be used to reduce the effects of mucositis in patients treated 
with RT.15,33,43 In a recent study by Gautam et al., LLLT treat-
ment of the oral cavity prior to RT showed decreased OM, oral 
pain, weight loss and the need for analgesic in elderly patients 
with HNC.15,43
Xerostomia 
Salivary glands are sensitive to RT. Xerostomia may manifest due 
to inflammation, fibrosis or degeneration of salivary glands. De-
creased flow is continuous throughout RT and may persist post-
treatment, increasing the risk of infections and the development of 
dental caries.36 Current treatments for xerostomia hope to increase 
the existing salivary flow or replace lost secretions, maintain proper 
oral hygiene, control dental caries that may be present and treat 
any arising infections. The presence or absence of residual oral cav-
ity secretions determines appropriate treatment.42
Xerostomia treatments include muscarinic acetylcholine 
agonists, salivary substitutes or stimulants, acupuncture and hy-
perbaric oxygen therapy (HBOT). Some examples of muscarinic 
acetylcholine agonists are pilocarpine and cevimeline. The con-
tinued administration of topical pilocarpine lozenges has been 
found to be superior to other treatments for improving unstimu-
lated and stimulated salivary flow rates.44
Alternative treatments include mechanical, gustatory or electri-
cal salivary stimulants. If salivary secretion stimulation fails, 
mouthwash or saliva substitutes that mimic natural saliva may 
be prescribed. Because of the increased risk for dental caries 
and infections, patients require frequent dental visits. Patients 
must be active in managing xerostomia by performing daily self- 
examinations for the presence of any white, red or dark-pigmented 
lesions, ulcerations or tooth decay.42,44 
Infections
Radiation-induced xerostomia and mucosal ulcerations increase 
the risk of viral, bacterial or fungal infections. Common bacterial 
infections involve species of Staphylococci and Streptococci, Klebsi-
ella pneumonia, Pseudomonas aeruginosa and Escherichia coli.45 The 
most common infection is oral candidiasis (OC), an opportunistic 
fungal infection primarily associated with Candida albicans. The 
two types of acute OC found in this population are pseudomem-
branous and erythematous. Patients suffering from pseudomem-
branous OC may present with wipeable, white, patchy lesions, 
while erythematous OC manifests in the oral cavity as red dif-
fused lesions on the oral mucosa. Frequently coexisting during 
RT, OC is often mistaken as oropharyngeal mucositis. Common 
symptoms are generalized burning sensations and pain.35,46
The treatment for OC is topical antifungal medication. Sys-
temic antifungals are administered for more invasive infections. 
Antifungal agents that are fully absorbed from the GI tract, such 
as fluconazole, ketoconazole and itraconazole, appear to be more 
effective in preventing OC.44,47
Trismus and Fibrosis
Radiation-induced fibrosis and ischemia may lead to trismus dur-
ing or post-RT. Unmanaged trismus may cause difficulty in swal-
lowing. The main treatment for increasing mouth-opening is a 
constant exercise regimen.37 Nursing home patients experienc-
ing difficulty with exercising independently may manage exercise 
routines with the help of staff. Modified, custom-made mouth-
opening devices could be an alternative treatment.48
Post-radiation/chemotherapy  
Complications and Management
Long-term complications of radiotherapy and chemotherapy in-
clude xerostomia, osteoradionecrosis, rampant caries and radiation-
induced sarcomas. Severe cases of xerostomia can cause difficulty in 
speech and swallowing, making everyday tasks troublesome.49 
Residents in nursing homes might experience extreme dis-
comfort with removable prostheses because saliva promotes 
bonding between the interface of prosthesis and the oral/gingi-
val tissue.50,51 Xerostomia treatment includes salivary stimulants, 
mouth moisteners and parasympathomimetic drugs. Side effects 
might be sweating, headache, rhinitis, dizziness and urinary fre-
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quency.52-56 Persistent xerostomia can lead to rampant caries. 
Effective preventive therapies include maintenance of good oral 
hygiene, the use of fluoride and chlorhexidine rinse.52 Conven-
tional glass ionomers are the restorative material of choice be-
cause of their bond strength and fluoride release.25
Most cases of osteoradionecrosis occur as the result of trau-
matic incidents, such as tooth extraction, biopsies, periodontal 
disease, subgingival scaling or ill-fitting prostheses.20 After radio-
therapy, edentulous patients should not wear dentures for at least 
one year. Dental implants can be placed successfully in irradi-
ated bone 12 to 18 months after completion of radiotherapy.58 
Although rare, treatment with radiation can cause post-radiation 
sarcomas.57 Therefore, any suspicious lesion should be sent for 
biopsy. If the lesion is found to be malignant, surgical resection 
is often the main treatment of choice.51 The oral and maxillofa-
cial surgeon can aid in post-radiation/chemotherapy therapy by 
helping patients through the rehabilitation process.29,30
Prostheses are essential to help patients regain normal func-
tion and improve facial aesthetics. Prostheses include dentures, as 
well as treatments for other portions of the face and neck. Because 
tissues actively heal and change after surgery, a close follow-up of 
the fit of the prostheses and assessment of functional jaw im-
provement is recommended.59 Patients, with the help of the nurs-
ing staff, should perform frequent oral examinations to identify 
any abnormal changes occurring in the oral cavity.15 The dentist 
can help by performing monthly oral examinations for residents 
for the first six months after completion of their treatment(s) 
and semiannually thereafter.59 An oral medicine specialist should 
be notified whenever oral pathology is suspected.15
Adjunctive Treatment
Innovative cancer treatments are keeping patients alive longer, 
resulting in complex disabilities, including fibrosis of irradiated 
tissue, trismus, dermatitis, and severe, acute mucositis and oro-
pharyngeal.53,56 Radiation-induced tissue damage occurs from 
injury to the endothelial cells lining small blood vessels, result-
ing in inflammation, ischemia and interstitial edema.60 Edema 
in the head and neck causes facial disfigurement; in severe cases, 
swelling of eyelids and lips can lead to difficulties in eating, as 
well as impaired vision.55 Traditional nursing measures, such as 
compression garments, ambulation and elevation, contribute to 
a reduction in lymphedema. Radiation dermatitis symptoms may 
be alleviated by skin care instructions, the use of aloe vera gels 
and water-based lotions, avoiding chemical irritants, and limiting 
sun and wind exposure. Massage and position changes can allevi-
ate the pressure sores of bedridden patients.60 
Patients should be aware of support services, such as physical, 
manual and occupational therapy, to reduce deconditioning and 
muscle atrophy. Manual therapy includes passive/active stretch-
ing and joint manipulation to increase range of motion (ROM) 
and reduce inflammation, hypoxia and contractile tensions.61 A 
novel technique is trigger-point dry-needling, which decreases 
pain and increases cervical ROM and blood flow to the site in 
patients having upper myofascial pain.62 Various jaw ROM exer-
cises and mechanical assistance devices, such as Therabite (Atos 
Medical, Sweden), can help increase ROM.63 Fibrosis can result in 
impaired movement of the muscles of mastication, tongue, pha-
ryngeal constrictors and larynx, resulting in swallowing dysfunc-
tion and risk for aspiration.63-65 Tongue-stretching, as an adjunct 
to the supraglottic swallowing maneuver, helps with coordination 
of chewing and swallowing.63 
Prevention counseling in oral hygiene, nutrition, alcohol and 
smoking should be offered. Smoking after a cancer diagnosis de-
creases the effectiveness of radiotherapy, shortens survival time 
and increase the risks of recurrence, second primary malignan-
cies and treatment complication.65 Cryotherapy (e.g., sucking 
on ice chips) can also lower the incidence of mucositis during 
infusions of chemotherapeutic agents by causing local vasocon-
striction, thus reducing exposure of cells to the drug.39,63 Pain 
associated with mucositis can be alleviated by using mouthrinses 
(Table 2) and gargling several times a day with warm salt water or 
a baking soda solution.66 
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TABLE 2.  
Natural Adjunctive Mouthrinse Recommendations for Mucositis  
Secondary to Chemotherapy and/or Radiation for Cancer Treatment
Management/Therapy Patient Diagnosis Results Type Study/Level Evidence Author/Year
Rinse containing olive leaf 
extract (OLE) or benzydamine 
hydrochloride
Chemotherapy-induced 
mucositis—25 patients given 
mouthrinse with OLE, 25 
patients given mouthrinse with 
benzydamine hydrochloride, 
25 patients given placebo 
mouthrinse.
Oral mucositis rates and severity 
were lower in OLE and Benzyda-
mine groups compared to placebo. 
Decrease in pro-inflammatory 
cytokine production.
Double-blind RCT, Level I Ahmed (2012)64
Calendula officinalis (English 
marigold) flowers extract 
mouthwash as oral gel on 
radiation-induced oropharyn-
geal mucositis (OM) 
38 patients with HNC under-
going radiotherapy (60 Gy) 
or concurrent chemoradiother-
apy were randomly assigned 
to receive either 2% calendula 
extract mouthwash or placebo 
(20 patients in each group).
OMAS scores were significantly 
lower in calendula group com-
pared to placebo at week 2, 3 
and 6 of the study.
According to repeated measures 
ANOVA test, the differences 
between OMAS of calendula and 
placebo during the weeks of evalu-
ation were statistically significant 
(p < 0.001). 
RCT, Level I Babaee (2013)77
Korean red ginseng  
(liquid concentrate) only
Radiotherapy only
RT+ KRG group
(20 Gy) Radiation-induced 
oral mucositis.
Rats in RT+ KRG group had less 
severe mucositis, fewer ulcerative 
mucosal lesions on the tongue, less 
hair loss, less rapid decrease in 
weight than did the RT-only group.
RCT, Level I Chang (2014)78
Dioctahedral smectite  
(natural absorbent clay  
of non-systemic specific  
aluminomagnesium silicate) 
and iodine glycerin (DSIG) 
cream vs. topical mouthrinse 
(composed of saline,  
gentamicin and Vitamin B
18 y.o. and older with 
pathological confirmed 
malignant tumors or malignant 
hematological diseases, 
130 intensive chemotherapy 
or stem cells transplantation 
induced OM. 67 patients 
received topical mouthrinse 
and 63 patients received 
DSIG cream treatment.
A favorable, lower oral assess-
ment guideline (OAG) score was 
observed in DSIG cream treated 
patients. The iodine glycerin may 
function as an antifungal/antibac-
terial and decrease repair time. 
From day 2-5 topical mouthrinse 
patients had a higher OAG score 
than DSIG treated. “The mouthrinse 
shows a protective function prior to 
OM appearance.”
Prospective RCT, Level I Lin (2015)79
Curcumin mouthwash 20 adult cancer patients  
with radio-chemotherapy  
OM randomly divided into  
2 groups.
Curcumin mouthwash was found 
to be better than chlorhexidine 
mouthwash in terms of rapid  
wound healing and better  
patient compliance.
RCT, Level I Patil (2015)80
13 received an aloe vera 
mouthwash, 13 received  
benzydamine mouthwash.
26 HNC patients  
(receiving at least 50 Gy) 
with radiation-induced 
mucositis.
Aloe vera mouthwash was as  
beneficial as benzydamine mouth-
wash in alleviating the severity of 
radiation-induced mucositis and 
showed no side effects.
Triple Blind RCT, Level I Sahebjamee (2015)81
16 received polaprezinc,  
15 received azulene oral 
rinse (control).
31 HNC patients  
with radiotherapy or  
radiochemotherapy OM.
Incidence rate of mucositis, pain, 
xerostomia and taste disturbance 
was lower in polaprezinc group 
than control.
Prospective RCT, Level I Watanabe (2010)82
RCT: Randomized Control Trial
Gy: Grays
OMAS: Oral Mucositis Assessment Scale
HNC: Head and Neck Cancer
OM: Oropharyngeal Mucositis
KRG: Korean Red Ginseng
RT: Radiation therapy
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HNC patients are at high risk for malnutrition due to taste al-
terations, xerostomia from medications, parotid atrophy and ra-
diation-induced diarrhea (RID).65,66 The diagnosis of diminished 
swallowing function and odynophagia (painful swallowing) can be 
made by a speech language pathologist and treated by means of pos-
tures to control the bolus and other swallowing maneuvers. Twenty-
nine percent to sixty-six percent of patients will experience severe 
oral mucositis during treatment, which is why alternative ways to 
provide nutrition need to be found.67 Bolus modification by altering 
foods (mashed, puréed, thickened [fluids]) may make them safer to 
swallow.68 Feeding tubes can also offer additional nutritional sup-
port post-treatment, when oral consumption is too painful. 
Psychological support and speech rehabilitation can greatly 
improve the HNC patient’s mental health. Frequently used al-
ternatives include selenium, relaxation techniques, prayer, vita-
min C, meditation and distraction.69 Mild-to-moderate exercise 
can promote energy and boost quality of life and mood, despite 
feelings of tiredness.70 Care plans should be tailored to meet the 
needs of each individual.
Conclusion
The objective of this review is to stress the importance of inter-
professional collaboration and management for the treatment of 
patients undergoing various types of cancer therapy. Each health-
care provider has the knowledge to guide the geriatric population 
in nursing homes through the various phases of diagnosis, treat-
ment and health maintenance post-treatment. The dentist and 
allied dental health professional can assist the nursing home staff 
with patients’ oral hygiene and look for signs of recurrent disease. 
The goal of the interprofessional team is to increase overall health 
and quality of life. p
The authors thank the University of New England College of Dental Medicine 
and Northern New England Clinical Oncology Society for their support. Que-
ries about this article can be sent to Dr. Wiley at rwiley@une.edu.
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